Having trouble accessing articles? Reset your cache.

Small molecule FTO inhibitor to treat AML

DISEASE CATEGORY: Cancer

INDICATION: Acute myelogenous leukemia (AML)

Cell culture and mouse studies identified a benzohydroxamic acid-based FTO

Read the full 165 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE